Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer
Determine whether copies of the cystic fibrosis gene (pGT-1) can be delivered to the cells lining the nose of cystic fibrosis patients using cationic liposome (DMRIE/DOPE) mediated gene transfer.
|Study Design:||Primary Purpose: Treatment|
|Study Start Date:||August 1995|
|Primary Completion Date:||May 2001 (Final data collection date for primary outcome measure)|
PROTOCOL OUTLINE: Under direct visualization, patients receive lipid/DNA formulation (pGT-1 lipid complex) by syringe instillation over 30 minutes to the right inferior nasal turbinate.
Patients are followed daily for 7 days, twice a week for 3 weeks, every 2-3 weeks for 10 weeks, then every 3 months thereafter.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004471
|Study Chair:||Eric J. Sorscher||University of Alabama at Birmingham|